Ditchcarbon
  • Contact
  1. Organizations
  2. Viva Biotech Holdings
Public Profile
Health Services
CN
updated 2 months ago

Viva Biotech Holdings

Company website

Viva Biotech Holdings, a leading player in the biotechnology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2008, the company has established itself as a prominent provider of drug discovery services, specialising in structure-based drug design and high-throughput screening. Viva Biotech's unique offerings include its proprietary technology platforms that enhance the efficiency of drug development processes, setting it apart in a competitive market. With a strong focus on innovation, the company has achieved significant milestones, including collaborations with major pharmaceutical firms and a robust portfolio of successful projects. Recognised for its expertise and commitment to advancing biopharmaceutical research, Viva Biotech Holdings continues to solidify its position as a trusted partner in the global biotech landscape.

DitchCarbon Score

How does Viva Biotech Holdings's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

28

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

23

Industry Benchmark

Viva Biotech Holdings's score of 28 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

55%

Let us know if this data was useful to you

Viva Biotech Holdings's reported carbon emissions

In 2025, Viva Biotech Holdings reported total carbon emissions of approximately 371,399,000 kg CO2e, with a significant majority, about 369,861,000 kg CO2e, classified under Scope 3 emissions. This includes emissions from purchased goods and services (approximately 280,338,000 kg CO2e) and upstream transportation and distribution (about 42,044,000 kg CO2e). The company's Scope 1 and 2 emissions were reported at approximately 1,538,000 kg CO2e (market-based). For the previous year, 2024, total emissions were approximately 411,661,000 kg CO2e, with Scope 3 emissions again dominating at about 409,994,000 kg CO2e. The Scope 1 and 2 emissions for 2024 were around 1,667,000 kg CO2e (market-based). In 2023, the total emissions were approximately 415,007,000 kg CO2e, with Scope 3 emissions at about 413,340,000 kg CO2e. The Scope 1 and 2 emissions for that year were approximately 1,667,000 kg CO2e (market-based). Viva Biotech Holdings has not disclosed any specific reduction targets or initiatives, nor does it appear to have cascaded data from a parent organization. The company has not committed to any Science-Based Targets Initiative (SBTi) reduction targets or other formal climate pledges. The absence of detailed reduction strategies suggests a need for further commitment to climate action within the industry context.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2021202320242025
Scope 1
958,111.2
-
-
-
Scope 2
36,499,030
-
-
-
Scope 3
-
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Viva Biotech Holdings's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Viva Biotech Holdings is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Viva Biotech Holdings is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Parexel

US
•
Research and development services (73)
Updated 3 days ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 minutes ago

Iqvia

US
•
Health and social work services (85)
Updated about 13 hours ago

Pharmaron, Inc.

US
•
Chemicals nec
Updated 1 day ago

Lonza

CH
•
Pharmaceutical Preparation Manufacturing
Updated 1 minute ago

Medpace Holdings, Inc.

US
•
Research and development services (73)
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251013.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy